Dan Huang

Dan Huang


Early stage researcher at the Institute for Medical Information Processing, Biometry, and Epidemiology (IBE)

Project Title

Constructing estimands for overall survival within causal frame work for dynamic treatment schemes in oncology:
Simulation and a clinical trial example

Research Interest

Clinical cancer trials;
Estimand framework;
Survival analysis.



Prof. Dr. Eva Hoster

Curriculum Vitae


2022 – present:  Ph.D. Candidate in Medical Research: Epidemiology & Public Health, Ludwig-Maximilians-Universität, Munich (Germany);
2015-2017: Master of Science in Epidemiology, Ludwig-Maximilians-Universität, Munich (Germany);
2007-2012:  Bachelor of Medicine in Preventive Medicine, Sun Yat-Sen University, Guangzhou (China).


Nowakowski GS, Yoon DH, Peters A, Mondello P, Joffe E, Fleury I, Greil R, Ku M, Marks R, Kim K, Zinzani PL, Trotman J, Huang D, Waltl EE, Winderlich M, Kurukulasuriya NC, Ambarkhane S, Hess G, Salles G.
Improved Efficacy of Tafasitamab plus Lenalidomide versus Systemic Therapies for Relapsed/Refractory DLBCL: RE-MIND2, an Observational Retrospective Matched Cohort Study. Clin Cancer Res. 2022 Jun 8:OF1- OF15. doi: 10.1158/1078-0432.CCR-21-3648. Epub ahead of print. PMID: 35674661.

Gilles Salles, Budhaditya Goswami, Vincenzo Bagnardi, Debarshi Dey, Mark Winderlich, Sumeet Ambarkhane, Dan Huang, Grzegorz S. Nowakowski; Estimation of Long-Term Survival with Tafasitamab + Lenalidomide in Relapsed/Refractory Diffuse Large B-Cell  Lymphoma.
Blood 2020; 136 (Supplement 1): 9–10. doi: https://doi.org/10.1182/blood-2020-140398